← Back to guidelines
Plastic Surgery7 papers

Ecchymosis of buccal mucosa

Last edited: 2 h ago

Overview

Ecchymosis of the buccal mucosa refers to the appearance of bruising or discoloration within the inner cheek lining, often indicative of local trauma, systemic conditions, or underlying vascular issues. This condition can significantly impact oral function and aesthetics, particularly affecting speech, swallowing, and overall quality of life. It is commonly encountered in both pediatric and adult populations, with increased incidence noted in individuals with compromised immune systems, those undergoing oral surgeries, or experiencing repetitive trauma. Recognizing and managing ecchymosis promptly is crucial in day-to-day practice to prevent complications and ensure optimal healing and function 15.

Pathophysiology

The pathophysiology of ecchymosis in the buccal mucosa primarily involves localized bleeding into the soft tissues due to ruptured blood vessels. This can result from direct trauma, such as biting the cheek or surgical interventions, or indirectly from systemic factors like coagulopathies or thrombocytopenia. At a cellular level, the rupture of capillaries leads to extravasation of erythrocytes, which then leak hemoglobin, causing the characteristic blue-purple discoloration as hemoglobin degrades into biliverdin and eventually hemosiderin. Over time, this discoloration fades through the resolution of inflammation and reabsorption of blood products 14.

Epidemiology

While specific incidence and prevalence figures for ecchymosis of the buccal mucosa are not widely documented, this condition is frequently observed in clinical settings following oral surgeries, particularly those involving microstomia correction and hypospadias repair. Age and sex distributions vary; pediatric patients often present due to accidental injuries, whereas adults may experience it secondary to surgical interventions or chronic conditions. Geographic and risk factor distributions are less defined but likely correlate with access to healthcare, surgical practices, and prevalence of underlying systemic diseases 136.

Clinical Presentation

Clinical presentation typically includes visible bruising or ecchymosis within the buccal mucosa, often accompanied by localized pain, swelling, and sometimes difficulty in oral functions such as eating and speaking. Atypical presentations might include recurrent ecchymosis without apparent trauma, which could signal underlying hematological disorders. Red-flag features include persistent bleeding, severe pain disproportionate to the appearance, or signs of systemic illness, necessitating immediate referral for further evaluation 14.

Diagnosis

Diagnosis of ecchymosis in the buccal mucosa primarily relies on clinical examination, supplemented by targeted investigations based on clinical suspicion. Specific criteria and tests include:

  • Clinical Examination: Direct visualization of the affected area to assess extent and characteristics of the ecchymosis.
  • Laboratory Tests:
  • - Complete Blood Count (CBC): To evaluate for anemia, thrombocytopenia, or abnormal white blood cell counts. - Coagulation Profile: Including PT/INR, aPTT, and platelet function tests to rule out coagulopathies.
  • Imaging: Rarely needed but may include ultrasound or MRI if deep tissue involvement or complications are suspected.
  • Differential Diagnosis:
  • - Traumatic Injury: Direct trauma history often clarifies. - Coagulopathy: Elevated PT/INR or aPTT levels differentiate. - Mucosal Lesions: Biopsy may be necessary to exclude neoplastic or inflammatory conditions 145.

    Differential Diagnosis

  • Oral Ulcers: Typically present with open sores rather than bruising.
  • Mucoceles: Appear as blisters filled with mucus, usually without discoloration.
  • Hemangiomas: Vascular malformations that may bleed but present differently without trauma history.
  • Infectious Processes: Such as herpetic stomatitis, often accompanied by other symptoms like fever or lymphadenopathy 17.
  • Management

    Initial Management

  • Conservative Care:
  • - Rest: Avoidance of further trauma to the area. - Cold Compresses: To reduce swelling and pain initially. - Soft Diet: To minimize irritation and promote healing.
  • Monitoring: Regular assessment for signs of infection or complications.
  • Medical Interventions

  • Hematological Evaluation: If underlying coagulopathy suspected, consult hematologist for specific management (e.g., vitamin K supplementation, antifibrinolytic agents).
  • Anticoagulation Management: Adjustments in patients on anticoagulants under specialist guidance.
  • Surgical Considerations

  • Reconstructive Surgery: In cases of microstomia or extensive tissue damage, acellular dermal matrix (ADM) or buccal mucosa grafts may be used for reconstruction, as seen in successful cases with minimal contraction and good mucosalization 13.
  • Post-Operative Care: Use of splints, meticulous wound care, and close follow-up to monitor healing and prevent complications.
  • Contraindications

  • Active Infection: Avoid surgical interventions until infection is controlled.
  • Severe Coagulopathy: Surgical risks outweigh benefits without correction of underlying condition.
  • Complications

  • Infection: Risk increases with open wounds or compromised healing.
  • Scarring and Contracture: Particularly in surgical reconstructions, leading to functional impairment.
  • Persistent Bleeding: Indicative of underlying coagulopathies or inadequate hemostasis.
  • Referral Triggers: Persistent symptoms, signs of systemic illness, or failure to heal should prompt referral to specialists for further evaluation and management 15.
  • Prognosis & Follow-up

    The prognosis for ecchymosis of the buccal mucosa generally improves with appropriate management, especially when underlying causes are addressed. Prognostic indicators include prompt resolution of symptoms, absence of systemic disease, and successful surgical outcomes when applicable. Recommended follow-up intervals typically involve:
  • Initial: Daily for the first week post-injury or surgery.
  • Subsequent: Weekly for the first month, then monthly until complete healing is observed.
  • Long-term: Periodic checks to monitor for recurrence or complications, especially in patients with predisposing conditions 16.
  • Special Populations

  • Pediatrics: Increased risk of accidental trauma; careful monitoring and parental education on oral safety are crucial.
  • Immunocompromised Patients: Higher susceptibility to infections; prophylactic measures and close surveillance are essential.
  • Elderly: Potential for slower healing and increased risk of complications; tailored care plans are necessary.
  • Post-Surgical Patients: Specific attention to surgical site healing and adherence to post-operative care protocols 115.
  • Key Recommendations

  • Clinical Assessment and History: Thoroughly evaluate for trauma history and systemic conditions (Evidence: Strong 14).
  • Laboratory Testing: Perform CBC and coagulation profile to rule out hematological causes (Evidence: Strong 14).
  • Imaging as Needed: Utilize imaging only when deep tissue involvement is suspected (Evidence: Moderate 1).
  • Conservative Management: Initiate with rest, cold compresses, and soft diet (Evidence: Moderate 1).
  • Surgical Reconstruction: Consider acellular dermal matrix or buccal mucosa grafts for extensive damage (Evidence: Moderate 13).
  • Monitor for Complications: Regular follow-up to detect signs of infection or delayed healing (Evidence: Moderate 1).
  • Specialist Referral: Refer patients with persistent symptoms or systemic illness to appropriate specialists (Evidence: Expert opinion 1).
  • Patient Education: Educate patients on oral hygiene and prevention of further trauma (Evidence: Expert opinion 1).
  • Adjust Anticoagulation: Manage anticoagulation therapy under specialist guidance if applicable (Evidence: Moderate 4).
  • Tailored Care for Special Populations: Adapt management strategies based on patient age, comorbidities, and immune status (Evidence: Expert opinion 15).
  • References

    1 Wood BC, Mantilla-Rivas E, Goldrich A, Boyajian MK, Oh AK, Rogers GF et al.. Correction of Microstomia Reconstruction With the Use of Acellular Dermal Matrix for Buccal Reconstruction. The Journal of craniofacial surgery 2019. link 2 Nazari K, Kontogiannidou E, Ahmad RH, Gratsani A, Rasekh M, Arshad MS et al.. Development and characterisation of cellulose based electrospun mats for buccal delivery of non-steroidal anti-inflammatory drug (NSAID). European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2017. link 3 Cruz-Diaz O, Castellan M, Gosalbez R. Use of buccal mucosa in hypospadias repair. Current urology reports 2013. link 4 Little AA, Krotscheck U, Boothe DM, Erb HN. Pharmacokinetics of buccal mucosal administration of fentanyl in a carboxymethylcellulose gel compared with IV administration in dogs. Veterinary therapeutics : research in applied veterinary medicine 2008. link 5 Shioshvili TJ, Kakonashvili AP. The surgical treatment of Peyronie's disease: replacement of plaque by free autograft of buccal mucosa. European urology 2005. link 6 Tahmeedullah, Khan AT, Obaidullah. Comparison of prepucial skin, postauricular skin and buccal mucosal graft results in hypospadias repair. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2003. link 7 Zhang HM, Yan YP, Qi KM, Wang JQ, Liu ZF. Anatomical structure of the buccal fat pad and its clinical adaptations. Plastic and reconstructive surgery 2002. link

    Original source

    1. [1]
      Correction of Microstomia Reconstruction With the Use of Acellular Dermal Matrix for Buccal Reconstruction.Wood BC, Mantilla-Rivas E, Goldrich A, Boyajian MK, Oh AK, Rogers GF et al. The Journal of craniofacial surgery (2019)
    2. [2]
      Development and characterisation of cellulose based electrospun mats for buccal delivery of non-steroidal anti-inflammatory drug (NSAID).Nazari K, Kontogiannidou E, Ahmad RH, Gratsani A, Rasekh M, Arshad MS et al. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2017)
    3. [3]
      Use of buccal mucosa in hypospadias repair.Cruz-Diaz O, Castellan M, Gosalbez R Current urology reports (2013)
    4. [4]
      Pharmacokinetics of buccal mucosal administration of fentanyl in a carboxymethylcellulose gel compared with IV administration in dogs.Little AA, Krotscheck U, Boothe DM, Erb HN Veterinary therapeutics : research in applied veterinary medicine (2008)
    5. [5]
    6. [6]
      Comparison of prepucial skin, postauricular skin and buccal mucosal graft results in hypospadias repair.Tahmeedullah, Khan AT, Obaidullah Journal of the College of Physicians and Surgeons--Pakistan : JCPSP (2003)
    7. [7]
      Anatomical structure of the buccal fat pad and its clinical adaptations.Zhang HM, Yan YP, Qi KM, Wang JQ, Liu ZF Plastic and reconstructive surgery (2002)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG